EUVIMEDEUVIMED entdecken
Crossref

Exploring the clinical significance of miR‐148 expression variations in distinct subtypes of irritable bowel syndrome

Qun Ji, Fengxia Du, Yangyaxin Yu, Ying Li iD

Annals of Human Genetics · 2024

DOI: 10.1111/ahg.12543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Human Genetics, 2024. Verfasst von Qun Ji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Inner Mongolia Baogang Hospital, Baotou, Inner Mongolia, China. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: The Inner Mongolia Nature Foundation (Peripheral blood miR-148 serves as a new biomarker in ulcerative colitis).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable bowel syndrome (IBS) belongs to chronic functional gastrointestinal diseases featured by abdominal pain and changes in bowel habits. This study aimed to investigate the clinical significance of serum miR‐148 expression in different subtypes of IBS. We enrolled 86 IBS patients and 55 healthy controls. miR‐148 expression levels were assessed in IBS patients classified into IBS‐constipation (IBS‐C), IBS‐diarrhea (IBS‐D), and IBS‐mixed stool pattern (IBS‐M) subtypes. Receiver‐operating characteristic (ROC) curves were employed to evaluate the diagnostic potential of miR‐148 in distinguishing among IBS subtypes. Additionally, we analyzed the correlation between miR‐148 expression and clinical characteristics, including IBS symptom severity. miR‐148 expression was highest in IBS‐D (diarrhea) group, followed by IBS‐M and IBS‐C. With the exception of the IBS‐C group, miR‐148 expression was elevated in IBS patients compared to controls. ROC curve analysis demonstrated that serum miR‐148 exhibited higher diagnostic accuracy for discriminating IBS‐C and IBS‐D than IBS‐M. Correlation analysis revealed a positive relationship between serum miR‐148 relative expression and IBS symptom severity system scores. Univariate logistic analysis indicated a positive association between miR‐148 expression and IBS‐D and a negative correlation with IBS‐C. miR‐148 expression exhibits differential patterns among IBS subtypes and holds a potential to distinguish IBS‐C and IBS‐D. Furthermore, miR‐148 expression correlates with the severity of IBS symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeMicroRNAsHumansClinical RelevanceDiarrheaConstipation

Stichwörter der Autor:innen

IBS‐constipationIBS‐diarrheaIBS‐mixed stool patternirritable bowel syndromemiR‐148

Substanzen

MicroRNAsMIRN148 microRNA, human

Autor:innen und Institutionen

  • Department of General Practice, Inner Mongolia Baogang Hospital, Baotou, Inner Mongolia, China.
  • Department of Hospital Infection Management, Inner Mongolia Baogang Hospital, Baotou, Inner Mongolia, China.
  • Department of General Practice, Baotou Jiuyuan District Hospital, Baotou, Inner Mongolia, China.

ORCID-Profile: Ying Li

Förderung

  • The Inner Mongolia Nature Foundation (Peripheral blood miR-148 serves as a new biomarker in ulcerative colitis)

Zitieren

APA

Ji, Q., Du, F., Yu, Y., & Li, Y. (2024). Exploring the clinical significance of miR‐148 expression variations in distinct subtypes of irritable bowel syndrome. Annals of Human Genetics. https://doi.org/10.1111/ahg.12543

Vancouver

Ji Q, Du F, Yu Y, Li Y. Exploring the clinical significance of miR‐148 expression variations in distinct subtypes of irritable bowel syndrome. Annals of Human Genetics. 2024. doi:10.1111/ahg.12543

BibTeX
@article{Ji2024,
  author = {Ji, Qun and Du, Fengxia and Yu, Yangyaxin and Li, Ying},
  title = {Exploring the clinical significance of miR‐148 expression variations in distinct subtypes of irritable bowel syndrome},
  journal = {Annals of Human Genetics},
  year = {2024},
  doi = {10.1111/ahg.12543}
}
Kostenlos starten →